Senior Analyst

SWK Holdings Corporation
Job Location
14755 Preston Road
Suite 105
Dallas, TX 75254
Job Description


The Analyst will have general support responsibilities for senior management spanning transaction prosecution to back office assistance. The Analyst will report to senior management. Regarding transactions, the Analyst will take an active role in the evaluation and structuring of transactions, as well as assist with monitoring of current portfolio investments.  The Analyst will be working on a small deal team in a fast-paced, entrepreneurial environment.  Regarding back office duties, the Analyst will assist on ad hoc projects to support SWK’s accounting team, as well as assist on various other matters.



-  Perform deep dive product analysis & market research, and prepare due diligence reports

-  Prepare financial models, expected return scenarios

-  Liaise with internal staff, including Accounting and Legal, and external third parties, including lawyers, accountants, consultants, and investment bankers


Successful candidate must possess a strong entrepreneurial streak, as they will be part of a growing team with varied responsibilities throughout the Firm.  Additional requirements include:

-  2-5+ years experience in life sciences via management consulting, investment banking, business development, equity or credit experience on buy/sell side, or private equity

-  Bachelor's degree from a top-tier university; MBA/CFA a plus but not required

-  Strong analytical background / Excel skills particularly in the financial modeling area

-  Effective written and oral communication skills with a direct and open communication style

-  Self-motivated and highly productive in independent work; able to envision, prioritize and thoroughly complete projects autonomously without requiring guidance or hand-holding

-  Team fit

-  Strong links to Texas preferred

How to Apply

If you are interested, please send an email to with a copy of your current resume.


About Our Organization

SWK Holdings Corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. SWK’s primary focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Company believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes.  SWK provides capital through its own balance sheet as well as through its investment advisory clients.

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.